Children, Perennial Allergic Rhinitis (PAR), l-t Growth
NCT00641212 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 209
Last updated 2009-03-25
Summary
The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.
Conditions
- Perennial Allergic Rhinitis
Interventions
- DRUG
-
Budesonide
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bertil Andersson · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2003-04-30
- Completion
- 2003-04-30
More Related Trials
-
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
NCT00109486 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)
NCT01134705 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis
NCT00189449 ·Status: COMPLETED
-
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
NCT00289198 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
NCT00712920 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)
NCT00449072 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis
NCT00940953 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics
NCT00116883 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
NCT00720382 ·Status: COMPLETED ·Phase: PHASE3
-
Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
NCT01697956 ·Status: COMPLETED ·Phase: PHASE3
-
Airway Inflammation in Children With Allergic Rhinitis and Intervention
NCT02352168 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
NCT00783432 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis
NCT00132925 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
NCT00570492 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
NCT07291284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
NCT01368445 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis
NCT00988247 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
NCT00659750 ·Status: COMPLETED ·Phase: PHASE3
-
New Nasal Applicator / New Formulation - User Study
NCT00641979 ·Status: COMPLETED ·Phase: PHASE2
-
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
NCT00118729 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
NCT00660829 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
NCT01378429 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies
NCT00720278 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Allergic Rhinitis In Patients Who Also Have Asthma
NCT00296491 ·Status: COMPLETED ·Phase: PHASE4